When a brand-name drug is on the FDA shortage list ... If a patient’s pharmacy runs out of brand-name versions of their GLP-1 ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

Hims & Hers (NYSE:HIMS) has launched an online GLP ... GLP-1 prescriptions due to lack of availability. Both semaglutide and ...

[5] Dulaglutide: A type of glucagon-like peptide-1 (GLP-1) receptor agonist approved by the U.S. Food and Drug Administration ...

If you had come across the abbreviation GLP-1 a few years ago, chances are you’d have had no idea what it stood for. Intro to Greek lyric poetry? Low-level Great Lakes precipitation? A member of the ...

has been “resolved” and removed from the FDA’s shortage list, see our prior blog “GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug ...

Glucagon-like peptide medications that treat Type 2 diabetes and weight management continue to grow in popularity, though ...

Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Supergut – the first and only nutrition brand clinically-validated to improve ... and those who consumed Supergut while on a GLP-1 drug were 4x less likely to experience severe, GI-related ...

Despite their benefits, access to GLP-1 medications remains inequitable. Perceived high costs, inconsistent insurance ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...